Owlet Baby Care

What Owlet Baby Care does

Owlet Baby Care, Inc. (NYSE: OWLT), founded in 2013 and headquartered in Lehi, Utah, is a publicly traded digital health company that develops FDA-cleared smart baby monitors and a connected parenting platform. Its core product, the Dream Sock, is the first and only FDA De Novo-cleared over-the-counter pulse oximeter for infants, using photoplethysmography (PPG) to track pulse rate and oxygen saturation in real time with clinical-grade accuracy (±3% of arterial blood gas measurements across all Fitzpatrick skin types). The product portfolio spans Dream Sock, Dream Sight (2K HD video), Dream Duo (integrated bundle), BabySat (FDA-cleared prescription pulse oximeter for infants with medical needs), and Owlet360 (a $9.99/month or $99.99/year subscription for predictive sleep analytics and personalized insights). Revenue is generated through four channels: direct-to-consumer e-commerce (owletcare.com) and Amazon, prescription/DME distribution (AdaptHealth, PromptCare, 1 Natural Way), hospital consignment (e.g., Children's Hospital of the King's Daughters), and B2B employer benefits (Owlet for Orgs with VGM Group as inaugural partner). BabySat is reimbursable through 250+ insurance plans including 35 state Medicaid programs and TRICARE.

The company serves four distinct customer segments: parents of healthy infants (primary, consumer), parents of infants with cardiac/respiratory conditions (clinical), employers offering parental benefits (B2B), and healthcare providers/hospitals (EHR-integrated care pathways). Owlet's commercial footprint spans the United States, United Kingdom, Ireland, Europe, Australia, New Zealand, and (pending) India, with 2.5 million babies monitored across 30+ countries and 110,000+ paying Owlet360 subscribers as of early 2026. International expansion accelerated in 2024–2026 with regulatory approvals in the EU, UK, Australia (TGA), and India (CDSCO). In April 2026, co-founder Kurt Workman returned as President and CEO following the resignation of Jonathan Harris. Recent strategic initiatives include partnerships with Rhapsody and Locus Health for EHR/remote patient monitoring integration, a webAI partnership for private AI infrastructure, the announced Owlet OnCall telehealth platform (H2 2026), and a $30 million underwritten public offering in October 2025 to fund continued commercialization and R&D.

Name

Owlet Baby Care

Legal name

Owlet Baby Care, Inc.

Website

https://owletcare.com

Company type

Public

Founded year

2013

Operating status

Operating

Headcount range

101–250 employees

Short description

Owlet Baby Care (NYSE: OWLT) makes FDA-cleared smart baby monitors—Dream Sock, Dream Sight, Dream Duo, and BabySat prescription pulse oximeter—for parents of infants 0-18 months, sold via DTC, retail, DME partners, and employer benefits, with an Owlet360 subscription layer across 30+ countries.

Ownership category

akta.pro rank

Product category

Consumer Health Electronics / Smart Baby Monitors

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Maternal, Fetal & Neonatal Monitoring (CTG, Infant Wearables) (HLAHACAF)

akta.pro secondary industries

Maternal & Neonatal Remote Monitoring Platforms (HLACAFAC), Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB)

Keywords

• Smart baby monitors
• Infant health monitoring
• Pediatric medical devices
• Connected nursery systems
• Wearable pulse oximetry

Headquarters

HQ city

Lehi

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Marketing or Sales, Technology or R&D, Personnel, Supply Chain, Infrastructure

Revenue model

1. Hardware Sales: One-time hardware revenue from Dream Sock ($199.99-$299.99), Dream Sight ($69.99-$99.99), Dream Duo 3 bundle ($269.99-$379.99), and accessories. Products available on direct e-commerce, Amazon, and retail channels. HSA/FSA eligible purchases.
2. Owlet360 Subscription: Recurring subscription at $9.99/month or $99.99/year providing personalized health/sleep insights, daily morning reports, comparative sleep data with similar-aged babies, extended video storage (14 days), and white noise streaming. 110,000+ paying subscribers as of early 2026.
3. BabySat Prescription Device: FDA-cleared prescription pulse oximeter covered by 250+ insurance plans including 35 state Medicaid plans and TRICARE (9.5 million military beneficiaries). Distributed through DME partners PromptCare and 1 Natural Way with insurance reimbursement.
4. Owlet for Orgs Employer Benefits: B2B employer benefit program where companies provide Owlet infant monitoring products to new/expecting parents as workplace benefit. Revenue from enterprise licensing/sale to employer groups.

Pricing tiers

Go-to-market motion4 records

Distribution channels10 records

Marketing channels8 records

Core offering

Owlet Baby Care designs, manufactures, and sells FDA-cleared connected health and video monitoring devices for infants, including the Dream Sock wearable pulse oximeter, Dream Sight 2K HD video monitor, Dream Duo integrated system, and the prescription-grade BabySat pulse oximeter. The company monetizes these devices through direct-to-consumer hardware sales plus the Owlet360 recurring subscription that delivers personalized AI-driven sleep and health insights on top of its 17+ trillion heartbeat proprietary dataset.

Product overview

Owlet Baby Care operates as a digital parenting platform offering connected nursery ecosystems and medical-grade infant health monitoring solutions. The product portfolio centers on FDA-cleared smart baby monitors: Dream Sock (pulse rate and oxygen tracking), Dream Sight (2K HD video monitoring), and Dream Duo (integrated wearable + video system). BabySat provides prescription-based clinical monitoring. Owlet360 delivers subscription-based personalized health and sleep insights powered by a proprietary dataset exceeding 17 trillion tracked heartbeats. The platform integrates hospital-grade infant health technology into retail accessible products, targeting both consumer and clinical care pathways with insurance-covered options and employer benefit programs.

Differentiator

Problem solved

Functional benefit

Brands

• Owlet360: Premium subscription service providing advanced personalized health, sleep, and comfort insights for Owlet devices, including daily morning reports, comparative sleep data, and 14-day video history.
• BabySat
• Dream Sock
• Dream Sight
• Dream Duo

Products and services

• Dream Sock FDA-cleared smart baby monitor using medical-grade pulse oximetry (photoplethysmography) to provide real-time pulse rate and oxygen readings for infants 1-18 months. First and only FDA-cleared OTC baby monitor, validated for SpO2 accuracy within +/- 3% of gold-standard arterial blood gas measurements across all skin tones.
• Dream Sight

Quantifiable outcome

• 96% of parents report reduced anxiety with Owlet monitoring
• +5 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability6 records

Feature5 records

Partnerships

Nine partnerships are on record, tiered minor and core.

• VGM GroupminorChannel Partner/ Reseller/ Distributor · 16 April 2026Inaugural employer partner for Owlet for Orgs employer benefit program. Employee-owned company supporting working parents provides infant health monitoring devices to new and expecting parents at the workplace.
• Children's Hospital Los AngelesminorOthers · 26 March 2026$39,000 donation of medical-grade infant monitoring products to CHLA NICCU as part of Make March Matter campaign. Supports families in critical neonatal care, reflecting Owlet's commitment to health equity and pediatric wellness.
• Hannah Cranston MediacoreGTM or Marketing Partner · 24 February 2026Selected as public relations agency of record following competitive review. Award-winning agency leading earned media and global PR strategy. Deploying Generative Engine Optimization framework to enhance discoverability across AI-powered search platforms and traditional media.
• PromptCarecoreChannel Partner/ Reseller/ Distributor · 11 February 2026Strategic DME partnership with national respiratory services provider to expand BabySat prescription pulse oximeter distribution across key U.S. regions. Leverages PromptCare's 25+ locations and established relationships with children's hospitals to strengthen Owlet's clinical and DME footprint through established pediatric care pathways.
• webAIcoreTechnology or Integration · 3 February 2026Strategic AI partnership to develop secure, personalized infant health and sleep insights using Owlet's proprietary data. Establishes private, enterprise-grade AI architecture ensuring data privacy, regulatory alignment, and scalability as Owlet expands globally.
• 1 Natural WaycoreChannel Partner/ Reseller/ Distributor · 18 December 2025DME partnership expanding insurance-covered access to BabySat through commercial plans, state Medicaid networks, and TRICARE (9.5 million military beneficiaries). 1 Natural Way manages benefits verification and documentation support to reduce friction for families and referring providers.
• RhapsodycoreTechnology or Integration · 12 November 2025Partnership to connect infant health data from Owlet's FDA-cleared BabySat directly into EHR workflows through standards-based integration. Creates secure pathway enabling clinicians to view and record real-time infant vital signs as part of standard patient records.
• Children's Hospital of the King's DaughterscoreStrategic or Co-development Partner · 1 September 2025First hospital consignment agreement enabling infants to be prescribed BabySat within hospital setting. Patients obtain insurance authorization before discharge and continue monitoring at home. Marks expansion into hospital prescribing channel.
• AdaptHealthcoreChannel Partner/ Reseller/ DistributorPrimary prescription fulfillment partner for BabySat. Coordinates with prescribing physicians, processes insurance authorizations, provides 2-day air shipping. Family can start order online with insurance information for benefits verification.

Scale indicators16 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Nanit: Nanit is a direct competitor in the smart baby monitor category, offering computer-vision-based video monitors with sleep tracking analytics. Competes with Owlet's Dream Sight and Dream Duo on the DTC parenting tech shelf and shares the same core buyer (health-conscious new parents).
• Miku: Miku (formerly Miku Pro) is a direct competitor selling a smart baby monitor with contactless breathing and sleep tracking. Competes head-to-head with Dream Sock/Dream Duo on premium infant monitoring features and shares Owlet's DTC premium positioning.
• Hatch (Hatch Baby): Hatch sells connected sound machines, sleep aids, and baby monitors. Overlaps with Owlet on the connected nursery ecosystem and targets the same new-parent demographic via DTC and retail channels; competes on parenting tech shelf space.
• Lollipop Baby Monitor: Lollipop is a direct competitor selling smart video baby monitors with cry detection and movement monitoring. Targets the same premium DTC parenting segment and competes on retail shelf space and app-based monitoring features.
• iBaby Labs: iBaby Labs is a smaller direct competitor selling connected baby monitors with HD video and app-based monitoring. Competes with Dream Sight/Dream Duo on the consumer smart monitor shelf and the DTC online channel.

Broad incumbents

• Masimo: Masimo is the global leader in pulse oximetry technology used in hospitals. Compares to Owlet as the clinical reference standard for the underlying SpO2 sensing technology that Dream Sock and BabySat leverage for consumer/prescription use cases.
• Eufy (Anker Innovations): Eufy (Anker subsidiary) sells smart baby monitors at lower price points, directly competing with Dream Sight on video monitoring. Stronger on consumer electronics scale and retail distribution but lacks FDA-cleared health monitoring.
• VTech Communications: VTech is a major incumbent in consumer baby monitors and kids' electronics with broad retail distribution. While not focused on health monitoring, it competes with Owlet on the basic video monitor category at lower price points and mass-market scale.
• ResMed: ResMed is a global leader in connected health and respiratory monitoring with strong DME and clinical channel relationships. Compares to Owlet's BabySat clinical/DME strategy and provides a benchmark for scaling consumer-grade connected health devices into reimbursed care pathways.
• Philips Avent: Philips Avent is a broad incumbent in the baby products category with monitors and feeding products. Competes with Owlet on the baby monitor shelf at mass-market retailers and brings healthcare parent-brand credibility, though its monitors are not FDA-cleared health devices.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Instagraminstagram.com/owletcare
• Facebookfacebook.com/OwletBabyMonitors
• YouTubeyoutube.com/owletcare
• Xx.com/owletbabycare
• LinkedInlinkedin.com/company/owlet-care-monitors

Compliance12 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds12 records

Investors35 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Owlet Baby Care